Modified FOLFOX6

FOLFOX6 regimen

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Modified FOLFOX6, covering 2013-05-14 to 2022-05-24. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Bemarituzumab (FPA144) Combined With Modified FOLFOX6 (mFOLFOX6) in Gastric/Gastroesophageal Junction Cancer [Phase 2]

See pricing